Recurrent or Metastatic Nasopharyngeal Carcinoma
Oncology·MeSH: Nasopharyngeal Carcinoma
1 drug in development·1 company·0 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| nana-val | Viracta Therapeutics, Inc. (VIRX) |
Deep-dive into Recurrent or Metastatic Nasopharyngeal Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis